Invenra

Invenra Focuses on Developing Next-Generation Best-in-Class Biologics, with an Emphasis on Multispecific Antibodies and Their Derivatives. Since its inception, we have developed a broad and proprietary set of platform technologies to enable the discovery and development of novel therapies across a wide range of therapeutic targets. Initially focused on oncology, we and our partners leverage our platform to advance a pipeline of novel bispecific and multispecific antibody candidates, which have demonstrated unparalleled combinational specificity and best-in-class potential in preclinical studies to date. With our growing portfolio of innovative products, we intend to expand our pipeline into other disease categories, creatively optimizing candidates to address the most challenging therapeutic targets.